Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lustman, P. J.
Right arrow Articles by McGill, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lustman, P. J.
Right arrow Articles by McGill, J. B.
Related Collections
Right arrow Diabetes

Psychosomatic Medicine, Vol 59, Issue 3 241-250, Copyright © 1997 by American Psychosomatic Society

ORIGINAL ARTICLES

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial

PJ Lustman, LS Griffith, RE Clouse, KE Freedland, SA Eisen, EH Rubin, RM Carney and JB McGill
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA. lustmanp@psychiatry.wust1.edu

OBJECTIVE: Depression is a prevalent and chronic condition in diabetes and is associated with poor glucose regulation and poor compliance with diabetes treatment. This investigation evaluated the effects of nortriptyline on depression and glycemic control to see whether depression in diabetes is treatable and whether restoring mental health contributes to improved medical outcome. METHOD: Sixty-eight diabetic patients with poor glycemic control, 28 of whom had active major depression (DSM-IIIR), completed a randomized, placebo-controlled, double-blind trial involving 8 weeks of treatment with nortriptyline targeted to therapeutic plasma levels (50-150 ng/ml). Depression improvement was determined with the Beck Depression Inventory; glucose control was measured by glycated hemoglobin levels. Compliance behavior was assessed using medication dispensing devices and glucometers equipped with electronic memory. RESULTS: The reduction in depression symptoms was significantly greater in depressed patients treated with nortriptyline compared with those receiving placebo (-10.2 vs -5.8, p = .03). Nortriptyline was not statistically superior to placebo in reducing glycated hemoglobin of the depressed subjects (p = .5). However, path analysis indicated that the direct effect of nortriptyline was to worsen glycemic control whereas depression improvement had an independent beneficial effect on glycated hemoglobin. These findings were not explained by the relationships of nortriptyline treatment to weight change (r = -0.21, p = .31) or depression improvement to compliance with the protocol for self-monitoring of blood glucose (r = 0.01, p = .97). CONCLUSIONS: Major depression in diabetic patients can be effectively treated with nortriptyline at the expense of a direct hyperglycemic effect. Path analysis demonstrated a treatment-independent effect of depression improvement on glycemic control, suggesting that a more ideal antidepressant agent may both restore mental health and improve medical outcome.


This article has been cited by other articles:


Home page
 Diabetes CareHome page
D. Echeverry, P. Duran, C. Bonds, M. Lee, and M. B. Davidson
Effect of Pharmacological Treatment of Depression on A1C and Quality of Life in Low-Income Hispanics and African Americans With Diabetes: A randomized, double-blind, placebo-controlled trial
Diabetes Care, December 1, 2009; 32(12): 2156 - 2160.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. E. Aikens, D. W. Perkins, B. Lipton, and J. D. Piette
Longitudinal Analysis of Depressive Symptoms and Glycemic Control in Type 2 Diabetes
Diabetes Care, July 1, 2009; 32(7): 1177 - 1181.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
H. R. Bogner, K. H. Morales, E. P. Post, and M. L. Bruce
Diabetes, Depression, and Death: A randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT)
Diabetes Care, December 1, 2007; 30(12): 3005 - 3010.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Peyrot and R. R. Rubin
Behavioral and Psychosocial Interventions in Diabetes: A conceptual review
Diabetes Care, October 1, 2007; 30(10): 2433 - 2440.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Ismail, K. Winkley, D. Stahl, T. Chalder, and M. Edmonds
A Cohort Study of People With Diabetes and Their First Foot Ulcer: The role of depression on mortality
Diabetes Care, June 1, 2007; 30(6): 1473 - 1479.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
P. J. Lustman and R. E. Clouse
Depression in Diabetes: The Chicken or the Egg?
Psychosom Med, May 1, 2007; 69(4): 297 - 299.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. M. Williams, R. E. Clouse, B. D. Nix, E. H. Rubin, G. S. Sayuk, J. B. McGill, A. J. Gelenberg, P. S. Ciechanowski, I. B. Hirsch, and P. J. Lustman
Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes
Diabetes Care, April 1, 2007; 30(4): 801 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
A. Georgiades, N. Zucker, K. E. Friedman, C. J. Mosunic, K. Applegate, J. D. Lane, M. N. Feinglos, and R. S. Surwit
Changes in Depressive Symptoms and Glycemic Control in Diabetes Mellitus
Psychosom Med, April 1, 2007; 69(3): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. J. Lustman, M. M. Williams, G. S. Sayuk, B. D. Nix, and R. E. Clouse
Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion
Diabetes Care, March 1, 2007; 30(3): 459 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
T. Hardy, R. Sachson, S. Shen, M. Armbruster, and A. J.M. Boulton
Does Treatment With Duloxetine for Neuropathic Pain Impact Glycemic Control?
Diabetes Care, January 1, 2007; 30(1): 21 - 26.
[Abstract] [Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
A. Cherrington, G. X. Ayala, B. Sleath, and G. Corbie-Smith
Examining knowledge, attitudes, and beliefs about depression among latino adults with type 2 diabetes.
The Diabetes Educator, July 1, 2006; 32(4): 603 - 613.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. E. Elwing, P. J. Lustman, H. L. Wang, and R. E. Clouse
Depression, Anxiety, and Nonalcoholic Steatohepatitis
Psychosom Med, July 1, 2006; 68(4): 563 - 569.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Peyrot, R. R. Rubin, L. M. Siminerio, and on behalf of the International DAWN Advisory Panel
Physician and Nurse Use of Psychosocial Strategies in Diabetes Care: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study.
Diabetes Care, June 1, 2006; 29(6): 1256 - 1262.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
P. J. Lustman, R. E. Clouse, B. D. Nix, K. E. Freedland, E. H. Rubin, J. B. McGill, M. M. Williams, A. J. Gelenberg, P. S. Ciechanowski, and I. B. Hirsch
Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial.
Arch Gen Psychiatry, May 1, 2006; 63(5): 521 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. M. Williams, R. E. Clouse, and P. J. Lustman
Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor
Clin. Diabetes, April 1, 2006; 24(2): 79 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. M. Trief, P. C. Morin, R. Izquierdo, J. A. Teresi, J. P. Eimicke, R. Goland, J. Starren, S. Shea, and R. S. Weinstock
Depression and Glycemic Control in Elderly Ethnically Diverse Patients With Diabetes: The IDEATel Project
Diabetes Care, April 1, 2006; 29(4): 830 - 835.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. de Groot, B. Pinkerman, J. Wagner, and E. Hockman
Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients.
Diabetes Care, March 1, 2006; 29(3): 549 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
E. H. B. Lin, W. Katon, C. Rutter, G. E. Simon, E. J. Ludman, M. Von Korff, B. Young, M. Oliver, P. C. Ciechanowski, L. Kinder, et al.
Effects of Enhanced Depression Treatment on Diabetes Self-Care
Ann. Fam. Med, January 1, 2006; 4(1): 46 - 53.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
S. M. Frayne, J. H. Halanych, D. R. Miller, F. Wang, H. Lin, L. Pogach, E. J. Sharkansky, T. M. Keane, K. M. Skinner, C. S. Rosen, et al.
Disparities in Diabetes Care: Impact of Mental Illness
Arch Intern Med, December 12, 2005; 165(22): 2631 - 2638.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. M. Garrison, W. J. Katon, and L. P. Richardson
The Impact of Psychiatric Comorbidities on Readmissions for Diabetes in Youth
Diabetes Care, September 1, 2005; 28(9): 2150 - 2154.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
P. J. Lustman, R. E. Clouse, P. S. Ciechanowski, I. B. Hirsch, and K. E. Freedland
Depression-Related Hyperglycemia in Type 1 Diabetes: A Mediational Approach
Psychosom Med, March 1, 2005; 67(2): 195 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
W. J. Katon, M. Von Korff, E. H. B. Lin, G. Simon, E. Ludman, J. Russo, P. Ciechanowski, E. Walker, and T. Bush
The Pathways Study: A Randomized Trial of Collaborative Care in Patients With Diabetes and Depression
Arch Gen Psychiatry, October 1, 2004; 61(10): 1042 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
P. J. Lustman and R. E. Clouse
Section III: Practical Considerations in the Management of Depression in Diabetes
Diabetes Spectr, July 1, 2004; 17(3): 160 - 166.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. W. Williams Jr., W. Katon, E. H.B. Lin, P. H. Noel, J. Worchel, J. Cornell, L. Harpole, B. A. Fultz, E. Hunkeler, V. S. Mika, et al.
The Effectiveness of Depression Care Management on Diabetes-Related Outcomes in Older Patients
Ann Intern Med, June 15, 2004; 140(12): 1015 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
J. L. Jackson, K. DeZee, and E. Berbano
Can Treating Depression Improve Disease Outcomes?
Ann Intern Med, June 15, 2004; 140(12): 1054 - 1056.
[Full Text] [PDF]

Home page
 The Diabetes EducatorHome page
J. D. McKellar, K. Humphreys, and J. D. Piette
Depression Increases Diabetes Symptoms by Complicating Patients' Self-Care Adherence
The Diabetes Educator, May 1, 2004; 30(3): 485 - 492.
[PDF]

Home page
 Diabetes CareHome page
W. Katon, M. Von Korff, P. Ciechanowski, J. Russo, E. Lin, G. Simon, E. Ludman, E. Walker, T. Bush, and B. Young
Behavioral and Clinical Factors Associated With Depression Among Individuals With Diabetes
Diabetes Care, April 1, 2004; 27(4): 914 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. A. Black, K. S. Markides, and L. A. Ray
Depression Predicts Increased Incidence of Adverse Health Outcomes in Older Mexican Americans With Type 2 Diabetes
Diabetes Care, October 1, 2003; 26(10): 2822 - 2828.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Peyrot
Depression: A Quiet Killer by Any Name
Diabetes Care, October 1, 2003; 26(10): 2952 - 2953.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Kruse, N. Schmitz, and W. Thefeld
On the Association Between Diabetes and Mental Disorders in a Community Sample: Results from the German National Health Interview and Examination Survey
Diabetes Care, June 1, 2003; 26(6): 1841 - 1846.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
R. E. Clouse, P. J. Lustman, K. E. Freedland, L. S. Griffith, J. B. McGill, and R. M. Carney
Depression and Coronary Heart Disease in Women With Diabetes
Psychosom Med, May 1, 2003; 65(3): 376 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. M. Desai, R. A. Rosenheck, B. G. Druss, and J. B. Perlin
Mental Disorders and Quality of Diabetes Care in the Veterans Health Administration
Am J Psychiatry, September 1, 2002; 159(9): 1584 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes Spectr.Home page
G. Welch and D. W. Guthrie
Supporting Lifestyle Change With a Computerized Psychosocial Assessment Tool
Diabetes Spectr, July 1, 2002; 15(3): 203 - 207.
[Full Text] [PDF]

Home page
 PsychosomaticsHome page
G. C. Smith, D. M. Clarke, D. Handrinos, and D. P. McKenzie
Consultation-Liaison Psychiatrists' Use of Antidepressants in the Physically Ill
Psychosomatics, June 1, 2002; 43(3): 221 - 227.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. W. Newcomer, D. W. Haupt, R. Fucetola, A. K. Melson, J. A. Schweiger, B. P. Cooper, and G. Selke
Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia
Arch Gen Psychiatry, April 1, 2002; 59(4): 337 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. A. Posternak, M. Zimmerman, G. I. Keitner, and I. W. Miller
A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Am J Psychiatry, February 1, 2002; 159(2): 191 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
M. A.L. Van Tilburg, C. C. McCaskill, J. D. Lane, C. L. Edwards, A. Bethel, M. N. Feinglos, and R. S. Surwit
Depressed Mood Is a Factor in Glycemic Control in Type 1 Diabetes
Psychosom Med, July 1, 2001; 63(4): 551 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
M. de Groot, R. Anderson, K. E. Freedland, R. E. Clouse, and P. J. Lustman
Association of Depression and Diabetes Complications: A Meta-Analysis
Psychosom Med, July 1, 2001; 63(4): 619 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. J. Anderson, K. E. Freedland, R. E. Clouse, and P. J. Lustman
The Prevalence of Comorbid Depression in Adults With Diabetes: A meta-analysis
Diabetes Care, June 1, 2001; 24(6): 1069 - 1078.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
P. S. Ciechanowski, W. J. Katon, and J. E. Russo
Depression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Arch Intern Med, November 27, 2000; 160(21): 3278 - 3285.
[Abstract] [Full Text] [PDF]

Home page
 Arch Fam MedHome page
P. A. Nutting, K. Rost, J. Smith, J. J. Werner, and C. Elliot
Competing Demands From Physical Problems: Effect on Initiating and Completing Depression Care Over 6 Months
Arch Fam Med, November 1, 2000; 9(10): 1059 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
P. J. Goodnick, K. Breakstone, A. Kumar, B. Freund, and C L. DeVane
Nefazodone in Diabetic Neuropathy: Response and Biology
Psychosom Med, July 1, 2000; 62(4): 599 - 600.
[Full Text] [PDF]

Home page
 Psychosom. Med.Home page
P. J. Goodnick, L. Mendosa, A. Kumar, B. Freund, and C. L. DeVane
Sertraline in Diabetic Neuropathy: Response and Biology
Psychosom Med, May 1, 2000; 62(3): 461 - 462.
[Full Text] [PDF]

Home page
 BMJHome page
E. M Cassidy, D J O'Halloran, and S. Barry
Lesson of the week: Insulin as a substance of misuse in a patient with insulin dependent diabetes mellitus
BMJ, November 27, 1999; 319(7222): 1417 - 1418.
[Full Text]

Home page
 ANN INTERN MEDHome page
A. F. Shorr and F. G. Miller
Psychotherapy for Depression in Diabetes
Ann Intern Med, July 6, 1999; 131(1): 70 - 70.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Psychosomatic Society